Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
Chien-Ting Wu, Peter V. Lidsky, Yinghong Xiao, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1565-1576.e5
Open Access | Times Cited: 300

Showing 26-50 of 300 citing articles:

Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis
Honghao Lai, Manli Yang, Mingyao Sun, et al.
Metabolism (2022) Vol. 137, pp. 155330-155330
Open Access | Times Cited: 39
The Association Between COVID-19 and Thyroxine Levels: A Meta-Analysis
Yiru Chen, Xiuneng Li, Yu Dai, et al.
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 38
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?
Danny Jonigk, Christopher Werlein, Till Acker, et al.
Virchows Archiv (2022) Vol. 481, Iss. 2, pp. 139-159
Open Access | Times Cited: 37
The role of cell death in SARS-CoV-2 infection
Cui Yuan, Zhenling Ma, Jiufeng Xie, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 36
COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis
Ester A. Barreto, Amanda Stephane Cruz dos Passos, Flávio P. Veras, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 21
Open Access | Times Cited: 34
Regulation of the immune system by the insulin receptor in health and disease
Priya Makhijani, Paulo José Basso, Yi Tao Chan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 29
COVID-19 as a Trigger for Type 1 Diabetes
Yichen Wang, Hui Guo, Gongquan Wang, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 9, pp. 2176-2183
Closed Access | Times Cited: 29
New‐onset type 1 diabetes in children and adolescents as postacute sequelae of SARS‐CoV‐2 infection: A systematic review and meta‐analysis of cohort studies
Masoud Rahmati, Dong Keon Yon, Seung Won Lee, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 27
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas
Zaid Khreefa, Mallory T. Barbier, Ali Rıza Köksal, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 262-262
Open Access | Times Cited: 25
New-Onset Diabetes After COVID-19
Sun H. Kim, Ipsa Arora, Daniel S. Hsia, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 11, pp. e1164-e1174
Closed Access | Times Cited: 25
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Open Access | Times Cited: 23
Increased insulin resistance due to Long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection
Hussein Kadhem Al‐Hakeim, Haneen Tahseen Al-Rubaye, Abdulsahib S Jubran, et al.
Brazilian Journal of Psychiatry (2023)
Open Access | Times Cited: 23
Infection with SARS-CoV-2 can cause pancreatic impairment
Wei Deng, Linlin Bao, Zhiqi Song, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Targeting the transmembrane cytokine co-receptor neuropilin-1 in distal tubules improves renal injury and fibrosis
Yinzheng Li, Zheng Wang, Huzi Xu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Early and late endocrine complications of COVID-19
Paraskevi Kazakou, Stavroula Α. Paschou, Θεοδώρα Ψαλτοπούλου, et al.
Endocrine Connections (2021) Vol. 10, Iss. 9, pp. R229-R239
Open Access | Times Cited: 49
Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis
Hariprasath Prakash, Anna Skiada, Raees A. Paul, et al.
Journal of Fungi (2021) Vol. 7, Iss. 8, pp. 616-616
Open Access | Times Cited: 48
Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: A case report
Hironobu Sasaki, Arata Itoh, Yasuhiro Watanabe, et al.
Journal of Diabetes Investigation (2022) Vol. 13, Iss. 6, pp. 1105-1108
Open Access | Times Cited: 36
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets
Moufida Ben Nasr, Francesca D’Addio, Laura Montefusco, et al.
Diabetes (2022) Vol. 71, Iss. 7, pp. 1579-1590
Open Access | Times Cited: 35
COVID‐19 metabolism: Mechanisms and therapeutic targets
Tianshi Wang, Ying Cao, Haiyan Zhang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 33
Hyperglycemia and Loss of Redox Homeostasis in COVID-19 Patients
Marí­a Elena Soto, Verónica Guarner‐Lans, Eulises Díaz‐Díaz, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 932-932
Open Access | Times Cited: 31
Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis
Karim M. Aloul, Josefine Eilsø Nielsen, Erwin B. Defensor, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Rong Cao, Huimin Tian, Yu Zhang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 20

Scroll to top